Guidance for Allergan Inc. (AGN)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2019 | $16.55 | $16.43 | $15.10B – 15.40B | $15.20B |  Raised |
Details |
| 2019 | $16.36 | $16.31 | $15.00B – 15.30B | $15.39B | = Maintained | Details |
| Q2 2019 | $4.20 – $4.40 | $4.20 | $3.85B – 4.00B | $3.87B | Raised |
Details |
| 2018 | $15.25 – $16.00 | $15.50 | $15.00B – 15.30B | $15.33B | = Maintained | Details |
| 2018 | $15.65 – $16.25 | $15.65 | $15.15B – 15.35B | $15.22B | = Maintained | Details |
| 2018 | $3.80 – $4.10 | $3.90 | $3.75B – 3.90B | $3.77B | = Maintained | Details |
| 2018 | N/A | N/A | $15.55B – 15.70B | $15.61B | = Maintained | Details |
| 2018 | $16.00 – $16.50 | $16.08 | $15.45B – 15.60B | $15.31B | = Maintained | Details |
| Q2 2018 | $4.00 – $4.20 | $3.94 | $3.85B – 4.00B | $3.84B | = Maintained | Details |
| 2017 | $15.80 – $16.30 | $16.01 | $15.50B – 15.80B | $15.37B | = Maintained | Details |
| 2017 | $15.85 – $16.35 | $16.05 | $15.80B – 16.00B | $15.72B | = Maintained | Details |
| Q4 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2016 | N/A | N/A | $17.00B | $17.66B | = Maintained | Details |
| 2016 | $13.30 – $13.50 | $13.94 | $14.45B – 14.65B | $14.72B | = Maintained | Details |
| 2014 | $5.36 – $5.48 | $5.46 | $6.65B – 6.95B | $6.78B | = Maintained | Details |
| 2014 | $1.09 – $1.12 | $1.21 | $1.53B – 1.60B | $1.60B | = Maintained | Details |
| 2014 | $6.27 – $6.30 | $6.12 | $7.08B – 7.16B | $7.15B | = Maintained | Details |
| Q3 2014 | $1.80 – $1.83 | $1.74 | $1.85B – 1.92B | $1.87B | = Maintained | Details |
| 2013 | $4.75 – $4.83 | $4.74 | $5.90B – 6.20B | $6.27B | = Maintained | Details |
| 2013 | N/A | N/A | $6.00M | N/A | = Maintained | Details |
| 2013 | N/A | N/A | $6.13B – 6.20B | $6.21B | = Maintained | Details |
| 2013 | $4.70 – $4.76 | $4.76 | N/A | N/A | = Maintained | Details |
| Q4 2013 | N/A | N/A | $1.59B – 1.66B | $1.63B | = Maintained | Details |
| Q2 2013 | $1.18 – $1.20 | $1.22 | N/A | N/A | = Maintained | Details |
| 2012 | $4.15 – $4.19 | $4.17 | $5.65M – 5.80M | $5.85M | = Maintained | Details |
| 2012 | $4.17 – $4.19 | $4.17 | $5.70B – 5.77B | $5.82B | = Maintained | Details |
| 2012 | N/A | N/A | $5.65M – 5.85M | $5.89M | = Maintained | Details |
| Q4 2012 | $1.18 – $1.20 | $1.20 | $1.47B – 1.55B | $1.51B | = Maintained | Details |
| Q2 2012 | $1.04 – $1.06 | $1.09 | $1.45B – 1.50B | $1.51B | = Maintained | Details |
| Q1 2012 | $0.84 – $0.86 | $0.91 | $1.34M – 1.39M | $1.37M | = Maintained | Details |
| 2011 | $3.62 – $3.64 | $3.64 | $5.30B – 5.37B | $5.42B | = Maintained | Details |
| 2011 | $3.59 – $3.63 | $3.64 | $5.22B – 5.37B | $5.31B | Raised |
Details |
| 2011 | $3.62 – $3.64 | $3.64 | $5.30B – 2.39B | $5.42B | = Maintained | Details |
| Q4 2011 | $0.97 – $0.99 | $1.01 | $1.33B – 1.41B | $1.41B | = Maintained | Details |
| Q3 2011 | $0.88 – $0.90 | $0.91 | N/A | N/A | = Maintained | Details |
| Q2 2011 | $0.93 – $0.95 | $0.92 | N/A | N/A | = Maintained | Details |
| 2011 | $3.54 – $3.60 | $3.63 | $5.02B – 5.22B | $5.20B | = Maintained | Details |
| Q1 2011 | $0.71 – $0.73 | $0.78 | $1.17B – 1.22B | $1.20B | = Maintained | Details |
